2017
DOI: 10.1016/j.jsat.2017.08.006
|View full text |Cite
|
Sign up to set email alerts
|

American counselors' acceptance of non-abstinence outcome goals for clients diagnosed with co-occurring substance use and other psychiatric disorders

Abstract: Previous research has examined clinicians’ acceptance of non-abstinence for clients who have a substance use disorder (SUD), but many SUD clients also present with a psychiatric disorder. To evaluate the acceptability of non-abstinence as a final outcome goal for clients with co-occurring diagnoses, we recruited a nationwide sample of 751 American substance abuse counselors to complete a web-based questionnaire. Respondents rated the acceptability of limited/moderate consumption by clients diagnosed with each … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
12
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
4
2
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 28 publications
(13 citation statements)
references
References 34 publications
1
12
0
Order By: Relevance
“…The survey for this study was developed based on previously-published questionnaires designed to assess the acceptability of non-abstinence goals by British and American administrators and counselors working in addiction treatment agencies (Davis & Rosenberg, 2013; Rosenberg & Davis, 2014; Davis, Rosenberg, & Rosansky, 2017; Rosenberg & Melville, 2005; Rosenberg & Phillips, 2003). Each respondent was asked to rate how acceptable (Completely Acceptable = +2; Somewhat Acceptable = +1; Somewhat Unacceptable = −1; Completely Unacceptable = −2) it would be for a patient to pursue non-abstinence (defined as “moderate or controlled use of a substance”) as their intermediate or final outcome goal when they were diagnosed with one of 20 different types of substance use disorders: 10 types of substance-specific SUDs (alcohol, cannabis, opioids, sedatives, synthetic cathinones, methamphetamine, hallucinogens, tobacco, synthetic cannabis, cocaine) × 2 levels of diagnostic severity (ICD-10 Harmful Use, ICD-10 Dependence Syndrome; see column headings of Table 2).…”
Section: Methodsmentioning
confidence: 99%
“…The survey for this study was developed based on previously-published questionnaires designed to assess the acceptability of non-abstinence goals by British and American administrators and counselors working in addiction treatment agencies (Davis & Rosenberg, 2013; Rosenberg & Davis, 2014; Davis, Rosenberg, & Rosansky, 2017; Rosenberg & Melville, 2005; Rosenberg & Phillips, 2003). Each respondent was asked to rate how acceptable (Completely Acceptable = +2; Somewhat Acceptable = +1; Somewhat Unacceptable = −1; Completely Unacceptable = −2) it would be for a patient to pursue non-abstinence (defined as “moderate or controlled use of a substance”) as their intermediate or final outcome goal when they were diagnosed with one of 20 different types of substance use disorders: 10 types of substance-specific SUDs (alcohol, cannabis, opioids, sedatives, synthetic cathinones, methamphetamine, hallucinogens, tobacco, synthetic cannabis, cocaine) × 2 levels of diagnostic severity (ICD-10 Harmful Use, ICD-10 Dependence Syndrome; see column headings of Table 2).…”
Section: Methodsmentioning
confidence: 99%
“…Abstinence from alcohol remains the primary treatment target in most specialty treatment programs for alcohol use disorder (AUD; Davis and Rosenberg, 2013; Davis et al, 2017; Rosenberg and Davis, 1994) and is embedded in the program philosophies of many mutual‐help organizations (e.g., Alcoholics Anonymous). The U.S. Food and Drug Administration (FDA) recommends either abstinence or no heavy drinking days as primary clinical endpoints in alcohol medication development (FDA, 2015), and many definitions of AUD recovery focus on abstinence as a defining feature of recovery (Betty Ford Institute Consensus Panel, 2007; SAMHSA, 2011).…”
mentioning
confidence: 99%
“…A large survey of AOD counsellors working in comorbidity services (n = 751) found that many (71%) considered both clients' treatment history and individual context when assessing whether non-abstinence was an appropriate treatment goal for clients (Davis et al, 2017). When developing treatment goals, these AOD counsellors reported considering clients' AOD use history, treatment-related aspects (i.e.…”
Section: Create Collaborative Treatment Goals (N = 1)mentioning
confidence: 99%